Effects of Daunorubicin on Yeast Gene Expression
Author Information
Author(s): Rojas Marta, Casado Marta, Portugal José, Piña Benjamin
Primary Institution: Institut for Molecular Biology of Barcelona, IBMB-CSIC
Hypothesis
Does daunorubicin selectively inhibit certain gene regulons in yeast?
Conclusion
Daunorubicin treatment selectively represses genes involved in glycolysis while ribosomal protein genes remain unaffected or slightly activated.
Supporting Evidence
- Daunorubicin affected 14% of the yeast transcriptome.
- 195 genes were up-regulated while 280 genes were down-regulated.
- Down-regulated genes included those involved in glycolysis and alcohol metabolism.
- Ribosomal protein genes were not significantly affected by daunorubicin treatment.
Takeaway
Daunorubicin is a drug that can change how yeast cells use sugar, making it harder for them to grow, but it doesn't stop them from making proteins.
Methodology
The study used microarray analysis to assess gene expression changes in yeast treated with daunorubicin.
Limitations
The study focused on a specific model organism (yeast) and may not fully represent effects in higher organisms.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website